The most frequent grade 3 and 4 adverse events were hematologic toxicities
The most frequent grade 3 and 4 adverse events were hematologic toxicities. individuals got steady disease as greatest response. Both individuals who were specified as nonresponders had been removed from research ahead of two cycles of treatment, but are contained in the safety and effectiveness analyses. The median duration on research was 5.3?weeks as well…